MRD Monitoring in Acute Lymphoblastic Leukemia

0 Visualizzazioni
administrator
administrator
06/15/23

In this segment, Raoul Tibes, MD, PhD, discusses risk stratification based on minimal residual disease monitoring in patients with acute lymphoblastic leukemia achieve remission.

  • Categoria

Mostra di più

0 Commenti Ordina per

Nessun commento trovato

Commenti su Facebook

Avanti il prossimo